# Evaluation on the Effectiveness and Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery Stenosis

> **NCT05320185** · — · UNKNOWN · sponsor: **Shenzhen Raysight Intelligent Medical Technology Co., Ltd.** · enrollment: 615 (estimated)

## Conditions studied

- Coronary Artery Disease
- Artificial Intelligence
- Coronary Artery Stenosis
- CT Angiography

## Interventions

- **DEVICE:** RuiXin-CoronaryAI software

## Key facts

- **NCT ID:** NCT05320185
- **Lead sponsor:** Shenzhen Raysight Intelligent Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-28
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 615 (ESTIMATED)
- **Last updated:** 2022-09-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05320185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05320185, "Evaluation on the Effectiveness and Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery Stenosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05320185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*